FDA Approves Injectable Dosage Form for Horses

Summary

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect the approval of a new medication, phenylbutazone injection, for use in horses to alleviate musculoskeletal inflammatory conditions. The approval was granted following a submission by Sparhawk Laboratories, Inc. for an abbreviated new animal drug application (ANADA).